Detalhe da pesquisa
1.
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.
Rheumatology (Oxford)
; 62(6): 2122-2129, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282537
2.
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials.
J Dermatolog Treat
; 35(1): 2342383, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38632977
3.
Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials.
Dermatol Ther (Heidelb)
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739215
4.
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
Rheumatol Ther
; 11(3): 633-648, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498139
5.
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.
Rheumatol Ther
; 11(3): 617-632, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498141
6.
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials.
Dermatol Ther (Heidelb)
; 12(2): 407-418, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921669
7.
Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2.
RMD Open
; 8(2)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35701011
8.
Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial.
Dermatol Ther (Heidelb)
; 11(2): 487-497, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512666
9.
Six-Month Use of Droxidopa for Neurogenic Orthostatic Hypotension.
Mov Disord Clin Pract
; 6(3): 235-242, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30949555